Institutional | news_types | eHealth News | Page 370

The chemotherapy drug Yondelis (trabectedin) has been approved by the U.S. Food and Drug Administration to treat certain advanced or unresectable soft-tissue sarcomas.

FDA Approves Yondelis for Soft-Tissue Sarcoma

HealthDay.com - Oct 23, 2015 0

Drug sanctioned for liposarcoma or leiomyosarcoma

Coagadex (coagulation Factor X) has been approved by the U.S. Food and Drug Administration as the first coagulation factor replacement therapy for people with a rare blood disorder known as hereditary Factor X deficiency.

FDA Approves Coagadex for Rare Clotting Disorder

HealthDay.com - Oct 21, 2015 0

First coagulation therapy sanctioned for Factor X deficiency

Praxbind (idarucizumab) has been approved for use in patients who are taking the anticoagulant Pradaxa (dabigatran) when there is an urgent need to reverse Pradaxa's anticoagulant effects

FDA Approves Praxbind to Reverse Pradaxa’s Effect

HealthDay.com - Oct 19, 2015 0

Praxbind cleared for emergency use with Pradaxa when bleeding can't be controlled

Improved prescribing practices could help reduce opioid abuse and overdose deaths from those drugs

CDC: Prescribing Practices Key to Curbing Rx Abuse

HealthDay.com - Oct 16, 2015 0

Small number of doctors write most opioid prescriptions, study finds

When compared to 12 other industrialized nations

Americans Spend More on Health Care, but Fare Worse

HealthDay.com - Oct 12, 2015 0

Comparison with 12 industrialized nations shows more money spent, but life expectancy is lowest

A British nurse who survived Ebola has been hospitalized due to a delayed complication from her infection

Ebola Survivor’s Case Points to Delayed Complications

HealthDay.com - Oct 9, 2015 0

Health officials say the risk to the general public remains low

The U.S. Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with advanced non-small-cell lung cancer whose disease progressed despite platinum-based chemotherapy.

FDA Approves Expanded Use of Opdivo in Advanced Lung Cancer

HealthDay.com - Oct 9, 2015 0

Demonstrates survival benefit in both squamous and non-squamous non-small-cell lung cancer

The U.S. Food and Drug Administration on Monday expanded its approval for the Optune device to include newly diagnosed glioblastoma multiforme.

FDA Approves Optune Device for Newly Diagnosed Glioblastoma

HealthDay.com - Oct 7, 2015 0

Newly sanctioned to treat just-diagnosed patients, in combination with temozolomide

U.S. hospitals have made significant improvements to breastfeeding support programs in recent years

CDC: Hospitals Doing Better Job of Promoting Breastfeeding

HealthDay.com - Oct 7, 2015 0

Still, nearly 4 million infants are born each year in U.S., but only 14% in 'baby-friendly' hospitals

The U.S. Preventive Services Task Force (USPSTF) recommends colorectal cancer screening starting at age 50 years and continuing through age 75 years. These findings form the basis of a draft recommendation statement

USPSTF Recommends CRC Screening for 50- to 75-Year-Olds

HealthDay.com - Oct 6, 2015 0

Grade A recommendation for 50- to 75-year-olds; individualized decision urged for those age 76 to 85

1...369370371...395 Page 370 of 395

Archives